In-Depth Interviews
November 1, 2024
Share this article:
Explore the Q4 2025 IVD Performance Scorecard to see how major acquisitions and structural shifts are redefining the global diagnostics industry. Analyze how 11 leading companies are navigating China’s procurement reforms, the shift toward specialty assays, and the high-stakes race in rapid antimicrobial susceptibility
2025 MICI Q4 Shows S mall Increase in Overall Confidence from Q3 2025
Discover how ESG is reshaping healthcare—from sustainable imaging and energy‑efficient design to equity and governance strategies driving industry transformation.
